Clinical Trial Detail

NCT ID NCT02669914
Title MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

Durvalumab

Age Groups: adult

No variant requirements are available.